Reproducibility of NMR analysis of urine samples: Impact of sample preparation, storage conditions, and animal health status

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Schreier, Christina ^a   Kremer, Werner ^a,b   Huber, Fritz ^a   Neumann, Sindy ^a   Pagel, Philipp ^a   Lienemann, Kai ^c   Pestel, Sabine ^d  

^a NUMARES AG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c TU DORTMUND UNIVERSITY   (Germany)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; SOLVENT; 1,3 BUTADIENE DERIVATIVE; FUROSEMIDE; HEXACHLOROBUTADIENE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL HEALTH; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DATA PROCESSING; FEMALE; FREEZE THAWING; HEALTH STATUS; MALE; METABOLITE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SALINITY; STORAGE; STORAGE TEMPERATURE; URINALYSIS; URINE OSMOLALITY; URINE PH; ANIMAL; CHEMISTRY; CRYOPRESERVATION; DRUG EFFECT; FREEZING; LABORATORY DIAGNOSIS; METABOLOME; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; URINE; WISTAR RAT; DRUG EFFECTS; PROCEDURES;

ANIMALS; BUTADIENES; CRYOPRESERVATION; FEMALE; FREEZING; FUROSEMIDE; HEALTH STATUS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SODIUM CHLORIDE; SPECIMEN HANDLING; URINE;

EID: 84880151098     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/878374     Document Type: Article

References (35)

1. Fura A., Harper T. W., Zhang H., Fung L., Shyu W. C., Shift in pH of biological fluids during storage and processing: effect on bioanalysis. Journal of Pharmaceutical and Biomedical Analysis 2003 32 3 513 522 2-s2.0-0142217486 10.1016/S0731-7085(03)00159-6
2. 1H NMR-based metabonomics: recommendations for sample preparation and storage. Analytical Chemistry 2007 79 3 1181 1186 2-s2.0-33846986484 10.1021/ac061354x
3. 1H-NMR spectroscopy of mouse urine. Biological and Pharmaceutical Bulletin 2007 30 4 667 670 2-s2.0-34147150311 10.1248/bpb.30.667
4. Beckonert O., Keun H. C., Ebbels T. M. D., Bundy J., Holmes E., Lindon J. C., Nicholson J. K., Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nature Protocols 2007 2 11 2692 2703 2-s2.0-39149126712 10.1038/nprot.2007.376
5. Roberts N. B., Higgins G., Sargazi M., A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage. Clinical Chemistry and Laboratory Medicine 2010 48 1 81 87 2-s2.0-74549143705 10.1515/CCLM.2010.017
6. Veljkovic K., Rodríguez-Capote K., Bhayana V., Pickersgill R., Beattie J., Clark L., Kavsak P. A., Assessment of a four hour delay for urine samples stored without preservatives at room temperature for urinalysis. Clinical Biochemistry 2012 45 10-11 856 858 2-s2.0-84860642774 10.1016/j.clinbiochem.2012.04.010
7. 2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats. Journal of Pharmacology and Experimental Therapeutics 2000 292 1 288 294 2-s2.0-0033965154
8. Jonassen T. E. N., Sørensen A.-M., Petersen J. S., Andreasens F., Christensen S., Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis. Hepatology 2000 31 6 1224 1230 2-s2.0-0034038461
9. Pestel S., Krzykalla V., Weckesser G., Measurement of glomerular filtration rate in the conscious rat. Journal of Pharmacological and Toxicological Methods 2007 56 3 277 289 2-s2.0-35148850138 10.1016/j.vascn.2007. 03.001
10. Karajala V., Mansour W., Kellum J. A., Diuretics in acute kidney injury. Minerva Anestesiologica 2009 75 5 251 257 2-s2.0-67650104028
11. Jiang L., Huang J., Wang Y., Tang H., Eliminating the dication-induced intersample chemical-shift variations for NMR-based biofluid metabonomic analysis. Analyst 2012 137 18 4209 4219
12. US department of health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Guidance for Industry. Bioanalytical Method Validation 2001
13. Pestel S., Martin H.-J., Maier G.-M., Guth B., Effect of commonly used vehicles on gastrointestinal, renal, and liver function in rats. Journal of Pharmacological and Toxicological Methods 2006 54 2 200 214 2-s2.0-33747889758 10.1016/j.vascn.2006.02.006
14. Holmes E., Nicholson J. K., Nicholls A. W., Lindon J. C., Connor S. C., Polley S., Connelly J., The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemometrics and Intelligent Laboratory Systems 1998 44 1-2 245 255 2-s2.0-0032517858 10.1016/S0169-7439(98)00110-5
15. Kim H. S., Cha S. H., Abraham D. G., Cooper A. J. L., Endou H., Intranephron distribution of cysteine S-conjugate β -lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats. Archives of Toxicology 1997 71 3 131 141 2-s2.0-0031041496 10.1007/s002040050367
16. Saude E. J., Adamko D., Rowe B. H., Marrie T., Sykes B. D., Variation of metabolites in normal human urine. Metabolomics 2007 3 4 439 451 2-s2.0-36049042571 10.1007/s11306-007-0091-1
17. Slupsky C. M., Rankin K. N., Wagner J., Fu H., Chang D., Weljie A. M., Saude E. J., Lix B., Adamko D. J., Shah S., Greiner R., Sykes B. D., Marrie T. J., Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Analytical Chemistry 2007 79 18 6995 7004 2-s2.0-34548730771 10.1021/ac0708588
18. National Toxicology Program, Toxicology and carcinogenesis studies of chromium picolinate monohydrate (CAS No. 27882-76-4) in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program Technical Report Series 2010 356 556 1 190 2-s2.0-79952296060
19. Lienemann K., Plötz T., Pestel S., NMR-based urine analysis in rats: prediction of proximal tubule kidney toxicity and phospholipidosis. Journal of Pharmacological and Toxicological Methods 2008 58 1 41 49 2-s2.0-50049123227 10.1016/j.vascn.2008.06.002
20. Lienemann K., Plötz T., Fink G. A., Benediktsson J. A., Kittler J., Roli F., Stacking for ensembles of local experts in metabonomic applications. Multiple Classifier Systems 2009 5519 Berlin, Germany Springer 498 508 Lecture Notes in Computer Science 10.1007/978-3-642-02326-2-50
21. Spraul M., Neidig P., Klauck U., Kessler P., Holmes E., Nicholson J. K., Sweatman B. C., Salman S. R., Farrant R. D., Rahr E., Beddell C. R., Lindon J. C., Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples. Journal of Pharmaceutical and Biomedical Analysis 1994 12 10 1215 1225 2-s2.0-0027964789 10.1016/0731-7085(94)00073-5
22. Schölkopf B., Smola A. J., Learning With Kernels: Support Vector Machines, Regularization, Optimization and Beyond 2002 Cambridge, Mass, USA MIT Press
23. Holmes E., Nicholson J. K., Tranter G., Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chemical Research in Toxicology 2001 14 2 182 191 2-s2.0-0035107971 10.1021/tx000158x
24. Shockcor J. P., Holmes E., Metabonomic applications in toxicity screening and disease diagnosis. Current topics in medicinal chemistry 2002 2 1 35 51 2-s2.0-0002301232
25. 1H NMR spectroscopy-based metabolic phenotyping studies. Analytical Chemistry 2007 79 14 5204 5211 2-s2.0-34547190179 10.1021/ac070212f
26. 1H NMR: application in metabonomic toxicology studies. Analytical Chemistry 2005 77 14 4556 4562 2-s2.0-27644560273 10.1021/ac0503456
27. Bundesärztekammer Arbeitsgemeinschaft der deutschen Ärztekammern, Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen, gemäß Beschluss des Vorstandes der Bundesärztekammer vom 23.11.2007. Deutsches Ärzteblatt 2008 105 7 341 355. updated in, Deutsches Ärzteblatt, vol. 108, no. 43, pp. 2298-2304, 2011
28. Pan Z., Raftery D., Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Analytical and Bioanalytical Chemistry 2007 387 2 525 527 2-s2.0-33846109344 10.1007/s00216-006-0687-8
29. Veenstra T. D., Metabolomics: the final frontier? Genome Medicine 2012 4 4, article 40 2-s2.0-84860451927 10.1186/gm339
30. Welsh B. T., Mapes J., QC white paper: an overview of assay quality systems at myriad RBM Inc. Myriad RBM
31. Gronwald W., Klein M. S., Kaspar H., Fagerer S. R., Nürnberger N., Dettmer K., Bertsch T., Oefner P. J., Urinary metabolite quantification employing 2D NMR spectroscopy. Analytical Chemistry 2008 80 23 9288 9297 2-s2.0-57449094403 10.1021/ac801627c
32. Craig A., Cloarec O., Holmes E., Nicholson J. K., Lindon J. C., Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Analytical Chemistry 2006 78 7 2262 2267 2-s2.0-33645663178 10.1021/ac0519312
33. Mercier P., Lewis M. J., Chang D., Baker D., Wishart D. S., Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra. Journal of Biomolecular NMR 2011 49 3-4 307 323 2-s2.0-79958766718 10.1007/s10858-011-9480-x
34. 1H NMR spectra for improved metabolic biomarker recovery. Analytical Chemistry 2009 81 1 56 66 2-s2.0-58149477904 10.1021/ac8011544
35. Petri A. L., Høgdall C., Christensen I. J., Simonsen A. H., T'Jampens D., Hellmann M.-L., Kjaer S. K., Fung E. T., Høgdall E., Sample handling for mass spectrometric proteomic investigations of human urine. Proteomics 2008 2 9 1184 1193 2-s2.0-53549112757 10.1002/prca.200780010